New pill could offer hope to bowel cancer and gastrointestinal stromal tumor patients after failure of standard treatmen
Two phase 3 trials, published in The Lancet, have shown that a novel oral drug called regorafenib could offer survival benefits to people with bowel cancer or gastrointestinal stromal tumor following failure of existing treatm ...
Cancer
Nov 21, 2012 |
not rated yet |
0
Big disappointment: Citicoline does not improve functional, cognitive status in patients with traumatic brain injury
Although approved for use for treating traumatic brain injury (TBI) in nearly 60 countries, use of citicoline in a randomized trial that included more than 1,200 participants with TBI did not result in improvement in functional ...
Neuroscience
Nov 20, 2012 |
not rated yet |
0
|
Meditation expertise changes experience of pain
(Medical Xpress)—Meditation can change the way a person experiences pain, according to a new study by UW–Madison neuroscientists.
Neuroscience
Nov 16, 2012 |
5 / 5 (6) |
0
|
When the going gets tough, the tough get... more relief from a placebo?
Are you good at coping when life gets tough? Do people call you a straight-shooter? Will you help others without expecting anything in return?
Psychology & Psychiatry
Nov 15, 2012 |
5 / 5 (2) |
0
|
Massage therapy may enhance immunity in preterm infants
(HealthDay)—For stable, preterm infants, daily massage therapy (MT) is positively associated with higher natural killer (NK) cell cytotoxicity and weight gain, according to a study published online Nov. ...
Pediatrics
Nov 13, 2012 |
not rated yet |
0
AHA: Allogeneic stem cells OK in ischemic cardiomyopathy
(HealthDay)—For patients with ischemic cardiomyopathy (ICM), allogeneic bone marrow-derived mesenchymal stem cells (MSCs) are safe; and delivery of bone marrow mononuclear cells (BMC) to patients with ST-segment ...
Cardiology
Nov 07, 2012 |
not rated yet |
0
Daily doses of a new probiotic reduces 'bad' and total cholesterol
Two daily doses of a probiotic lowered key cholesterol-bearing molecules in the blood as well as "bad" and total cholesterol, in a study presented at the American Heart Association's Scientific Sessions 2012.
Cardiology
Nov 05, 2012 |
not rated yet |
0
|
Mayo Clinic identifies promising treatment for inherited form of kidney disease
A drug therapy shows promise for treating an inherited form of kidney disease called autosomal dominant polycystic kidney disease (ADPKD), Mayo Clinic researchers say. The medication, tolvaptan, slowed the pace of kidney ...
Diseases, Conditions, Syndromes
Nov 04, 2012 |
not rated yet |
0
Once-yearly zoledronic acid benefits men with osteoporosis
(HealthDay)—For men with osteoporosis, a once-yearly infusion with zoledronic acid is associated with fewer vertebral fractures and improved bone health compared with placebo, according to a study published ...
Diseases, Conditions, Syndromes
Nov 02, 2012 |
not rated yet |
0
Science of placebos seen from alternative point of view
(Medical Xpress)—With the perspective of a scientist trained in acupuncture, Alison Adams is well positioned to explain why placebos may be misunderstood—and why they should be understood in the first ...
Medications
Nov 02, 2012 |
not rated yet |
0
Latrepirdine not effective in Huntington's disease
(HealthDay)—Although safe and well tolerated, the experimental small molecule latrepirdine does not improve cognition after six months of treatment in patients with mild-to-moderate Huntington's disease ...
Neuroscience
Nov 01, 2012 |
not rated yet |
0
Buspirone improves symptoms in functional dyspepsia
(HealthDay)—Buspirone, a 5-hydroxytryptamine 1A receptor agonist, improves symptom severity in patients with functional dyspepsia (FD), according to a proof-of-concept study published in the November issue ...
Diseases, Conditions, Syndromes
Oct 29, 2012 |
not rated yet |
0
Hypnosis helps hot flashes
Hypnosis can help cut hot flashes by as much as 74%, shows a study supported by the National Center for Complementary and Alternative Medicine. This is the first controlled, randomized study of the technique to manage hot ...
Cancer
Oct 24, 2012 |
not rated yet |
0
Genetic marker for placebo response identified in IBS patients
Although placebos have played a critical role in medicine and clinical research for more than 70 years, it has been a mystery why these inactive treatments help to alleviate symptoms in some patients – and not others. Now ...
Diseases, Conditions, Syndromes
Oct 23, 2012 |
4 / 5 (1) |
0
|
Chinese herbs show promise for lung cancer, flu, and idiopathic pulmonary fibrosis
Chinese herbs, including JHQG, BFXL, and BFHX, may show significant benefits for patients with non-small cell lung cancer (NSCLC), idiopathic pulmonary fibrosis (IPF), and influenza.
Medications
Oct 22, 2012 |
not rated yet |
0
